Global Contact-Activated Lancet Market Insights, Forecast to 2030

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Contact-Activated Lancet Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Contact-Activated Lancet Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
  • 1.2.2 Below 30G
  • 1.2.3 Above 30G
• 1.3 Market by Application
  • 1.3.1 Global Contact-Activated Lancet Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Others
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Executive Summary

• 2.1 Global Contact-Activated Lancet Sales Estimates and Forecasts 2019-2030
• 2.2 Global Contact-Activated Lancet Revenue by Region
  • 2.2.1 Global Contact-Activated Lancet Revenue by Region: 2019 VS 2023 VS 2030
  • 2.2.2 Global Contact-Activated Lancet Revenue by Region (2019-2024)
  • 2.2.3 Global Contact-Activated Lancet Revenue by Region (2025-2030)
  • 2.2.4 Global Contact-Activated Lancet Revenue Market Share by Region (2019-2030)
• 2.3 Global Contact-Activated Lancet Sales Estimates and Forecasts 2019-2030
• 2.4 Global Contact-Activated Lancet Sales by Region
  • 2.4.1 Global Contact-Activated Lancet Sales by Region: 2019 VS 2023 VS 2030
  • 2.4.2 Global Contact-Activated Lancet Sales by Region (2019-2024)
  • 2.4.3 Global Contact-Activated Lancet Sales by Region (2025-2030)
  • 2.4.4 Global Contact-Activated Lancet Sales Market Share by Region (2019-2030)
• 2.5 US & Canada
• 2.6 Europe
• 2.7 China
• 2.8 Asia (excluding China)
• 2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

• 3.1 Global Contact-Activated Lancet Sales by Manufacturers
  • 3.1.1 Global Contact-Activated Lancet Sales by Manufacturers (2019-2024)
  • 3.1.2 Global Contact-Activated Lancet Sales Market Share by Manufacturers (2019-2024)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Contact-Activated Lancet in 2023
• 3.2 Global Contact-Activated Lancet Revenue by Manufacturers
  • 3.2.1 Global Contact-Activated Lancet Revenue by Manufacturers (2019-2024)
  • 3.2.2 Global Contact-Activated Lancet Revenue Market Share by Manufacturers (2019-2024)
  • 3.2.3 Global Top 10 and Top 5 Companies by Contact-Activated Lancet Revenue in 2023
• 3.3 Global Key Players of Contact-Activated Lancet, Industry Ranking, 2022 VS 2023 VS 2024
• 3.4 Global Contact-Activated Lancet Sales Price by Manufacturers
• 3.5 Analysis of Competitive Landscape
  • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.5.2 Global Contact-Activated Lancet Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.6 Global Key Manufacturers of Contact-Activated Lancet, Manufacturing Base Distribution and Headquarters
• 3.7 Global Key Manufacturers of Contact-Activated Lancet, Product Offered and Application
• 3.8 Global Key Manufacturers of Contact-Activated Lancet, Date of Enter into This Industry
• 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Contact-Activated Lancet Sales by Type
  • 4.1.1 Global Contact-Activated Lancet Historical Sales by Type (2019-2024)
  • 4.1.2 Global Contact-Activated Lancet Forecasted Sales by Type (2025-2030)
  • 4.1.3 Global Contact-Activated Lancet Sales Market Share by Type (2019-2030)
• 4.2 Global Contact-Activated Lancet Revenue by Type
  • 4.2.1 Global Contact-Activated Lancet Historical Revenue by Type (2019-2024)
  • 4.2.2 Global Contact-Activated Lancet Forecasted Revenue by Type (2025-2030)
  • 4.2.3 Global Contact-Activated Lancet Revenue Market Share by Type (2019-2030)
• 4.3 Global Contact-Activated Lancet Price by Type
  • 4.3.1 Global Contact-Activated Lancet Price by Type (2019-2024)
  • 4.3.2 Global Contact-Activated Lancet Price Forecast by Type (2025-2030)

5 Market Size by Application

• 5.1 Global Contact-Activated Lancet Sales by Application
  • 5.1.1 Global Contact-Activated Lancet Historical Sales by Application (2019-2024)
  • 5.1.2 Global Contact-Activated Lancet Forecasted Sales by Application (2025-2030)
  • 5.1.3 Global Contact-Activated Lancet Sales Market Share by Application (2019-2030)
• 5.2 Global Contact-Activated Lancet Revenue by Application
  • 5.2.1 Global Contact-Activated Lancet Historical Revenue by Application (2019-2024)
  • 5.2.2 Global Contact-Activated Lancet Forecasted Revenue by Application (2025-2030)
  • 5.2.3 Global Contact-Activated Lancet Revenue Market Share by Application (2019-2030)
• 5.3 Global Contact-Activated Lancet Price by Application
  • 5.3.1 Global Contact-Activated Lancet Price by Application (2019-2024)
  • 5.3.2 Global Contact-Activated Lancet Price Forecast by Application (2025-2030)

6 US & Canada

• 6.1 US & Canada Contact-Activated Lancet Market Size by Type
  • 6.1.1 US & Canada Contact-Activated Lancet Sales by Type (2019-2030)
  • 6.1.2 US & Canada Contact-Activated Lancet Revenue by Type (2019-2030)
• 6.2 US & Canada Contact-Activated Lancet Market Size by Application
  • 6.2.1 US & Canada Contact-Activated Lancet Sales by Application (2019-2030)
  • 6.2.2 US & Canada Contact-Activated Lancet Revenue by Application (2019-2030)
• 6.3 US & Canada Contact-Activated Lancet Market Size by Country
  • 6.3.1 US & Canada Contact-Activated Lancet Revenue by Country: 2019 VS 2023 VS 2030
  • 6.3.2 US & Canada Contact-Activated Lancet Sales by Country (2019-2030)
  • 6.3.3 US & Canada Contact-Activated Lancet Revenue by Country (2019-2030)
  • 6.3.4 US
  • 6.3.5 Canada

7 Europe

• 7.1 Europe Contact-Activated Lancet Market Size by Type
  • 7.1.1 Europe Contact-Activated Lancet Sales by Type (2019-2030)
  • 7.1.2 Europe Contact-Activated Lancet Revenue by Type (2019-2030)
• 7.2 Europe Contact-Activated Lancet Market Size by Application
  • 7.2.1 Europe Contact-Activated Lancet Sales by Application (2019-2030)
  • 7.2.2 Europe Contact-Activated Lancet Revenue by Application (2019-2030)
• 7.3 Europe Contact-Activated Lancet Market Size by Country
  • 7.3.1 Europe Contact-Activated Lancet Revenue by Country: 2019 VS 2023 VS 2030
  • 7.3.2 Europe Contact-Activated Lancet Sales by Country (2019-2030)
  • 7.3.3 Europe Contact-Activated Lancet Revenue by Country (2019-2030)
  • 7.3.4 Germany
  • 7.3.5 France
  • 7.3.6 U.K.
  • 7.3.7 Italy
  • 7.3.8 Netherlands

8 China

• 8.1 China Contact-Activated Lancet Market Size
  • 8.1.1 China Contact-Activated Lancet Sales (2019-2030)
  • 8.1.2 China Contact-Activated Lancet Revenue (2019-2030)
• 8.2 China Contact-Activated Lancet Market Size by Application
  • 8.2.1 China Contact-Activated Lancet Sales by Application (2019-2030)
  • 8.2.2 China Contact-Activated Lancet Revenue by Application (2019-2030)

9 Asia (excluding China)

• 9.1 Asia Contact-Activated Lancet Market Size by Type
  • 9.1.1 Asia Contact-Activated Lancet Sales by Type (2019-2030)
  • 9.1.2 Asia Contact-Activated Lancet Revenue by Type (2019-2030)
• 9.2 Asia Contact-Activated Lancet Market Size by Application
  • 9.2.1 Asia Contact-Activated Lancet Sales by Application (2019-2030)
  • 9.2.2 Asia Contact-Activated Lancet Revenue by Application (2019-2030)
• 9.3 Asia Contact-Activated Lancet Sales by Region
  • 9.3.1 Asia Contact-Activated Lancet Revenue by Region: 2019 VS 2023 VS 2030
  • 9.3.2 Asia Contact-Activated Lancet Revenue by Region (2019-2030)
  • 9.3.3 Asia Contact-Activated Lancet Sales by Region (2019-2030)
  • 9.3.4 Japan
  • 9.3.5 South Korea
  • 9.3.6 China Taiwan
  • 9.3.7 Southeast Asia
  • 9.3.8 India

10 Middle East, Africa and Latin America

• 10.1 Middle East, Africa and Latin America Contact-Activated Lancet Market Size by Type
  • 10.1.1 Middle East, Africa and Latin America Contact-Activated Lancet Sales by Type (2019-2030)
  • 10.1.2 Middle East, Africa and Latin America Contact-Activated Lancet Revenue by Type (2019-2030)
• 10.2 Middle East, Africa and Latin America Contact-Activated Lancet Market Size by Application
  • 10.2.1 Middle East, Africa and Latin America Contact-Activated Lancet Sales by Application (2019-2030)
  • 10.2.2 Middle East, Africa and Latin America Contact-Activated Lancet Revenue by Application (2019-2030)
• 10.3 Middle East, Africa and Latin America Contact-Activated Lancet Sales by Country
  • 10.3.1 Middle East, Africa and Latin America Contact-Activated Lancet Revenue by Country: 2019 VS 2023 VS 2030
  • 10.3.2 Middle East, Africa and Latin America Contact-Activated Lancet Revenue by Country (2019-2030)
  • 10.3.3 Middle East, Africa and Latin America Contact-Activated Lancet Sales by Country (2019-2030)
  • 10.3.4 Brazil
  • 10.3.5 Mexico
  • 10.3.6 Turkey
  • 10.3.7 Israel
  • 10.3.8 GCC Countries

11 Company Profiles

• 11.1 BD
  • 11.1.1 BD Company Information
  • 11.1.2 BD Overview
  • 11.1.3 BD Contact-Activated Lancet Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.1.4 BD Contact-Activated Lancet Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 BD Recent Developments
• 11.2 Accu-Chek (Roche)
  • 11.2.1 Accu-Chek (Roche) Company Information
  • 11.2.2 Accu-Chek (Roche) Overview
  • 11.2.3 Accu-Chek (Roche) Contact-Activated Lancet Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.2.4 Accu-Chek (Roche) Contact-Activated Lancet Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 Accu-Chek (Roche) Recent Developments
• 11.3 OneTouch (LifeScan)
  • 11.3.1 OneTouch (LifeScan) Company Information
  • 11.3.2 OneTouch (LifeScan) Overview
  • 11.3.3 OneTouch (LifeScan) Contact-Activated Lancet Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.3.4 OneTouch (LifeScan) Contact-Activated Lancet Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 OneTouch (LifeScan) Recent Developments
• 11.4 FreeStyle (Abbott)
  • 11.4.1 FreeStyle (Abbott) Company Information
  • 11.4.2 FreeStyle (Abbott) Overview
  • 11.4.3 FreeStyle (Abbott) Contact-Activated Lancet Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.4.4 FreeStyle (Abbott) Contact-Activated Lancet Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 FreeStyle (Abbott) Recent Developments
• 11.5 Microlet Next (Ascensia)
  • 11.5.1 Microlet Next (Ascensia) Company Information
  • 11.5.2 Microlet Next (Ascensia) Overview
  • 11.5.3 Microlet Next (Ascensia) Contact-Activated Lancet Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.5.4 Microlet Next (Ascensia) Contact-Activated Lancet Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 Microlet Next (Ascensia) Recent Developments
• 11.6 Terumo
  • 11.6.1 Terumo Company Information
  • 11.6.2 Terumo Overview
  • 11.6.3 Terumo Contact-Activated Lancet Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.6.4 Terumo Contact-Activated Lancet Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 Terumo Recent Developments
• 11.7 Genteel
  • 11.7.1 Genteel Company Information
  • 11.7.2 Genteel Overview
  • 11.7.3 Genteel Contact-Activated Lancet Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.7.4 Genteel Contact-Activated Lancet Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 Genteel Recent Developments
• 11.8 CareTouch
  • 11.8.1 CareTouch Company Information
  • 11.8.2 CareTouch Overview
  • 11.8.3 CareTouch Contact-Activated Lancet Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.8.4 CareTouch Contact-Activated Lancet Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 CareTouch Recent Developments
• 11.9 Pip Diabetes Care
  • 11.9.1 Pip Diabetes Care Company Information
  • 11.9.2 Pip Diabetes Care Overview
  • 11.9.3 Pip Diabetes Care Contact-Activated Lancet Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.9.4 Pip Diabetes Care Contact-Activated Lancet Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.9.5 Pip Diabetes Care Recent Developments
• 11.10 Owen Mumford
  • 11.10.1 Owen Mumford Company Information
  • 11.10.2 Owen Mumford Overview
  • 11.10.3 Owen Mumford Contact-Activated Lancet Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.10.4 Owen Mumford Contact-Activated Lancet Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.10.5 Owen Mumford Recent Developments
• 11.11 Trividia Health
  • 11.11.1 Trividia Health Company Information
  • 11.11.2 Trividia Health Overview
  • 11.11.3 Trividia Health Contact-Activated Lancet Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.11.4 Trividia Health Contact-Activated Lancet Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.11.5 Trividia Health Recent Developments
• 11.12 AUVON
  • 11.12.1 AUVON Company Information
  • 11.12.2 AUVON Overview
  • 11.12.3 AUVON Contact-Activated Lancet Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.12.4 AUVON Contact-Activated Lancet Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.12.5 AUVON Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Contact-Activated Lancet Industry Chain Analysis
• 12.2 Contact-Activated Lancet Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Contact-Activated Lancet Production Mode & Process
• 12.4 Contact-Activated Lancet Sales and Marketing
  • 12.4.1 Contact-Activated Lancet Sales Channels
  • 12.4.2 Contact-Activated Lancet Distributors
• 12.5 Contact-Activated Lancet Customers

13 Market Dynamics

• 13.1 Contact-Activated Lancet Industry Trends
• 13.2 Contact-Activated Lancet Market Drivers
• 13.3 Contact-Activated Lancet Market Challenges
• 13.4 Contact-Activated Lancet Market Restraints

14 Key Findings in The Global Contact-Activated Lancet Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details
• 15.3 Disclaimer

List of Tables

• Table 1. Global Contact-Activated Lancet Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
• Table 2. Major Manufacturers of Below 30G
• Table 3. Major Manufacturers of Above 30G
• Table 4. Global Contact-Activated Lancet Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
• Table 5. Global Contact-Activated Lancet Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
• Table 6. Global Contact-Activated Lancet Revenue by Region (2019-2024) & (US$ Million)
• Table 7. Global Contact-Activated Lancet Revenue by Region (2025-2030) & (US$ Million)
• Table 8. Global Contact-Activated Lancet Revenue Market Share by Region (2019-2024)
• Table 9. Global Contact-Activated Lancet Revenue Market Share by Region (2025-2030)
• Table 10. Global Contact-Activated Lancet Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
• Table 11. Global Contact-Activated Lancet Sales by Region (2019-2024) & (K Units)
• Table 12. Global Contact-Activated Lancet Sales by Region (2025-2030) & (K Units)
• Table 13. Global Contact-Activated Lancet Sales Market Share by Region (2019-2024)
• Table 14. Global Contact-Activated Lancet Sales Market Share by Region (2025-2030)
• Table 15. Global Contact-Activated Lancet Sales by Manufacturers (2019-2024) & (K Units)
• Table 16. Global Contact-Activated Lancet Sales Share by Manufacturers (2019-2024)
• Table 17. Global Contact-Activated Lancet Revenue by Manufacturers (2019-2024) & (US$ Million)
• Table 18. Global Contact-Activated Lancet Revenue Share by Manufacturers (2019-2024)
• Table 19. Global Key Players of Contact-Activated Lancet, Industry Ranking, 2022 VS 2023 VS 2024
• Table 20. Contact-Activated Lancet Price by Manufacturers 2019-2024 (US$/Unit)
• Table 21. Global Contact-Activated Lancet Manufacturers Market Concentration Ratio (CR5 and HHI)
• Table 22. Global Contact-Activated Lancet by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Contact-Activated Lancet as of 2023)
• Table 23. Global Key Manufacturers of Contact-Activated Lancet, Manufacturing Base Distribution and Headquarters
• Table 24. Global Key Manufacturers of Contact-Activated Lancet, Product Offered and Application
• Table 25. Global Key Manufacturers of Contact-Activated Lancet, Date of Enter into This Industry
• Table 26. Mergers & Acquisitions, Expansion Plans
• Table 27. Global Contact-Activated Lancet Sales by Type (2019-2024) & (K Units)
• Table 28. Global Contact-Activated Lancet Sales by Type (2025-2030) & (K Units)
• Table 29. Global Contact-Activated Lancet Sales Share by Type (2019-2024)
• Table 30. Global Contact-Activated Lancet Sales Share by Type (2025-2030)
• Table 31. Global Contact-Activated Lancet Revenue by Type (2019-2024) & (US$ Million)
• Table 32. Global Contact-Activated Lancet Revenue by Type (2025-2030) & (US$ Million)
• Table 33. Global Contact-Activated Lancet Revenue Share by Type (2019-2024)
• Table 34. Global Contact-Activated Lancet Revenue Share by Type (2025-2030)
• Table 35. Contact-Activated Lancet Price by Type (2019-2024) & (US$/Unit)
• Table 36. Global Contact-Activated Lancet Price Forecast by Type (2025-2030) & (US$/Unit)
• Table 37. Global Contact-Activated Lancet Sales by Application (2019-2024) & (K Units)
• Table 38. Global Contact-Activated Lancet Sales by Application (2025-2030) & (K Units)
• Table 39. Global Contact-Activated Lancet Sales Share by Application (2019-2024)
• Table 40. Global Contact-Activated Lancet Sales Share by Application (2025-2030)
• Table 41. Global Contact-Activated Lancet Revenue by Application (2019-2024) & (US$ Million)
• Table 42. Global Contact-Activated Lancet Revenue by Application (2025-2030) & (US$ Million)
• Table 43. Global Contact-Activated Lancet Revenue Share by Application (2019-2024)
• Table 44. Global Contact-Activated Lancet Revenue Share by Application (2025-2030)
• Table 45. Contact-Activated Lancet Price by Application (2019-2024) & (US$/Unit)
• Table 46. Global Contact-Activated Lancet Price Forecast by Application (2025-2030) & (US$/Unit)
• Table 47. US & Canada Contact-Activated Lancet Sales by Type (2019-2024) & (K Units)
• Table 48. US & Canada Contact-Activated Lancet Sales by Type (2025-2030) & (K Units)
• Table 49. US & Canada Contact-Activated Lancet Revenue by Type (2019-2024) & (US$ Million)
• Table 50. US & Canada Contact-Activated Lancet Revenue by Type (2025-2030) & (US$ Million)
• Table 51. US & Canada Contact-Activated Lancet Sales by Application (2019-2024) & (K Units)
• Table 52. US & Canada Contact-Activated Lancet Sales by Application (2025-2030) & (K Units)
• Table 53. US & Canada Contact-Activated Lancet Revenue by Application (2019-2024) & (US$ Million)
• Table 54. US & Canada Contact-Activated Lancet Revenue by Application (2025-2030) & (US$ Million)
• Table 55. US & Canada Contact-Activated Lancet Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
• Table 56. US & Canada Contact-Activated Lancet Revenue by Country (2019-2024) & (US$ Million)
• Table 57. US & Canada Contact-Activated Lancet Revenue by Country (2025-2030) & (US$ Million)
• Table 58. US & Canada Contact-Activated Lancet Sales by Country (2019-2024) & (K Units)
• Table 59. US & Canada Contact-Activated Lancet Sales by Country (2025-2030) & (K Units)
• Table 60. Europe Contact-Activated Lancet Sales by Type (2019-2024) & (K Units)
• Table 61. Europe Contact-Activated Lancet Sales by Type (2025-2030) & (K Units)
• Table 62. Europe Contact-Activated Lancet Revenue by Type (2019-2024) & (US$ Million)
• Table 63. Europe Contact-Activated Lancet Revenue by Type (2025-2030) & (US$ Million)
• Table 64. Europe Contact-Activated Lancet Sales by Application (2019-2024) & (K Units)
• Table 65. Europe Contact-Activated Lancet Sales by Application (2025-2030) & (K Units)
• Table 66. Europe Contact-Activated Lancet Revenue by Application (2019-2024) & (US$ Million)
• Table 67. Europe Contact-Activated Lancet Revenue by Application (2025-2030) & (US$ Million)
• Table 68. Europe Contact-Activated Lancet Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
• Table 69. Europe Contact-Activated Lancet Revenue by Country (2019-2024) & (US$ Million)
• Table 70. Europe Contact-Activated Lancet Revenue by Country (2025-2030) & (US$ Million)
• Table 71. Europe Contact-Activated Lancet Sales by Country (2019-2024) & (K Units)
• Table 72. Europe Contact-Activated Lancet Sales by Country (2025-2030) & (K Units)
• Table 73. China Contact-Activated Lancet Sales by Type (2019-2024) & (K Units)
• Table 74. China Contact-Activated Lancet Sales by Type (2025-2030) & (K Units)
• Table 75. China Contact-Activated Lancet Revenue by Type (2019-2024) & (US$ Million)
• Table 76. China Contact-Activated Lancet Revenue by Type (2025-2030) & (US$ Million)
• Table 77. China Contact-Activated Lancet Sales by Application (2019-2024) & (K Units)
• Table 78. China Contact-Activated Lancet Sales by Application (2025-2030) & (K Units)
• Table 79. China Contact-Activated Lancet Revenue by Application (2019-2024) & (US$ Million)
• Table 80. China Contact-Activated Lancet Revenue by Application (2025-2030) & (US$ Million)
• Table 81. Asia Contact-Activated Lancet Sales by Type (2019-2024) & (K Units)
• Table 82. Asia Contact-Activated Lancet Sales by Type (2025-2030) & (K Units)
• Table 83. Asia Contact-Activated Lancet Revenue by Type (2019-2024) & (US$ Million)
• Table 84. Asia Contact-Activated Lancet Revenue by Type (2025-2030) & (US$ Million)
• Table 85. Asia Contact-Activated Lancet Sales by Application (2019-2024) & (K Units)
• Table 86. Asia Contact-Activated Lancet Sales by Application (2025-2030) & (K Units)
• Table 87. Asia Contact-Activated Lancet Revenue by Application (2019-2024) & (US$ Million)
• Table 88. Asia Contact-Activated Lancet Revenue by Application (2025-2030) & (US$ Million)
• Table 89. Asia Contact-Activated Lancet Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
• Table 90. Asia Contact-Activated Lancet Revenue by Region (2019-2024) & (US$ Million)
• Table 91. Asia Contact-Activated Lancet Revenue by Region (2025-2030) & (US$ Million)
• Table 92. Asia Contact-Activated Lancet Sales by Region (2019-2024) & (K Units)
• Table 93. Asia Contact-Activated Lancet Sales by Region (2025-2030) & (K Units)
• Table 94. Middle East, Africa and Latin America Contact-Activated Lancet Sales by Type (2019-2024) & (K Units)
• Table 95. Middle East, Africa and Latin America Contact-Activated Lancet Sales by Type (2025-2030) & (K Units)
• Table 96. Middle East, Africa and Latin America Contact-Activated Lancet Revenue by Type (2019-2024) & (US$ Million)
• Table 97. Middle East, Africa and Latin America Contact-Activated Lancet Revenue by Type (2025-2030) & (US$ Million)
• Table 98. Middle East, Africa and Latin America Contact-Activated Lancet Sales by Application (2019-2024) & (K Units)
• Table 99. Middle East, Africa and Latin America Contact-Activated Lancet Sales by Application (2025-2030) & (K Units)
• Table 100. Middle East, Africa and Latin America Contact-Activated Lancet Revenue by Application (2019-2024) & (US$ Million)
• Table 101. Middle East, Africa and Latin America Contact-Activated Lancet Revenue by Application (2025-2030) & (US$ Million)
• Table 102. Middle East, Africa and Latin America Contact-Activated Lancet Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
• Table 103. Middle East, Africa and Latin America Contact-Activated Lancet Revenue by Country (2019-2024) & (US$ Million)
• Table 104. Middle East, Africa and Latin America Contact-Activated Lancet Revenue by Country (2025-2030) & (US$ Million)
• Table 105. Middle East, Africa and Latin America Contact-Activated Lancet Sales by Country (2019-2024) & (K Units)
• Table 106. Middle East, Africa and Latin America Contact-Activated Lancet Sales by Country (2025-2030) & (K Units)
• Table 107. BD Company Information
• Table 108. BD Description and Major Businesses
• Table 109. BD Contact-Activated Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 110. BD Contact-Activated Lancet Product Model Numbers, Pictures, Descriptions and Specifications
• Table 111. BD Recent Developments
• Table 112. Accu-Chek (Roche) Company Information
• Table 113. Accu-Chek (Roche) Description and Major Businesses
• Table 114. Accu-Chek (Roche) Contact-Activated Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 115. Accu-Chek (Roche) Contact-Activated Lancet Product Model Numbers, Pictures, Descriptions and Specifications
• Table 116. Accu-Chek (Roche) Recent Developments
• Table 117. OneTouch (LifeScan) Company Information
• Table 118. OneTouch (LifeScan) Description and Major Businesses
• Table 119. OneTouch (LifeScan) Contact-Activated Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 120. OneTouch (LifeScan) Contact-Activated Lancet Product Model Numbers, Pictures, Descriptions and Specifications
• Table 121. OneTouch (LifeScan) Recent Developments
• Table 122. FreeStyle (Abbott) Company Information
• Table 123. FreeStyle (Abbott) Description and Major Businesses
• Table 124. FreeStyle (Abbott) Contact-Activated Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 125. FreeStyle (Abbott) Contact-Activated Lancet Product Model Numbers, Pictures, Descriptions and Specifications
• Table 126. FreeStyle (Abbott) Recent Developments
• Table 127. Microlet Next (Ascensia) Company Information
• Table 128. Microlet Next (Ascensia) Description and Major Businesses
• Table 129. Microlet Next (Ascensia) Contact-Activated Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 130. Microlet Next (Ascensia) Contact-Activated Lancet Product Model Numbers, Pictures, Descriptions and Specifications
• Table 131. Microlet Next (Ascensia) Recent Developments
• Table 132. Terumo Company Information
• Table 133. Terumo Description and Major Businesses
• Table 134. Terumo Contact-Activated Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 135. Terumo Contact-Activated Lancet Product Model Numbers, Pictures, Descriptions and Specifications
• Table 136. Terumo Recent Developments
• Table 137. Genteel Company Information
• Table 138. Genteel Description and Major Businesses
• Table 139. Genteel Contact-Activated Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 140. Genteel Contact-Activated Lancet Product Model Numbers, Pictures, Descriptions and Specifications
• Table 141. Genteel Recent Developments
• Table 142. CareTouch Company Information
• Table 143. CareTouch Description and Major Businesses
• Table 144. CareTouch Contact-Activated Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 145. CareTouch Contact-Activated Lancet Product Model Numbers, Pictures, Descriptions and Specifications
• Table 146. CareTouch Recent Developments
• Table 147. Pip Diabetes Care Company Information
• Table 148. Pip Diabetes Care Description and Major Businesses
• Table 149. Pip Diabetes Care Contact-Activated Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 150. Pip Diabetes Care Contact-Activated Lancet Product Model Numbers, Pictures, Descriptions and Specifications
• Table 151. Pip Diabetes Care Recent Developments
• Table 152. Owen Mumford Company Information
• Table 153. Owen Mumford Description and Major Businesses
• Table 154. Owen Mumford Contact-Activated Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 155. Owen Mumford Contact-Activated Lancet Product Model Numbers, Pictures, Descriptions and Specifications
• Table 156. Owen Mumford Recent Developments
• Table 157. Trividia Health Company Information
• Table 158. Trividia Health Description and Major Businesses
• Table 159. Trividia Health Contact-Activated Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 160. Trividia Health Contact-Activated Lancet Product Model Numbers, Pictures, Descriptions and Specifications
• Table 161. Trividia Health Recent Developments
• Table 162. AUVON Company Information
• Table 163. AUVON Description and Major Businesses
• Table 164. AUVON Contact-Activated Lancet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
• Table 165. AUVON Contact-Activated Lancet Product Model Numbers, Pictures, Descriptions and Specifications
• Table 166. AUVON Recent Developments
• Table 167. Key Raw Materials Lists
• Table 168. Raw Materials Key Suppliers Lists
• Table 169. Contact-Activated Lancet Distributors List
• Table 170. Contact-Activated Lancet Customers List
• Table 171. Contact-Activated Lancet Market Trends
• Table 172. Contact-Activated Lancet Market Drivers
• Table 173. Contact-Activated Lancet Market Challenges
• Table 174. Contact-Activated Lancet Market Restraints
• Table 175. Research Programs/Design for This Report
• Table 176. Key Data Information from Secondary Sources
• Table 177. Key Data Information from Primary Sources

List of Figures

• Figure 1. Contact-Activated Lancet Product Picture
• Figure 2. Global Contact-Activated Lancet Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
• Figure 3. Global Contact-Activated Lancet Market Share by Type in 2023 & 2030
• Figure 4. Below 30G Product Picture
• Figure 5. Above 30G Product Picture
• Figure 6. Global Contact-Activated Lancet Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
• Figure 7. Global Contact-Activated Lancet Market Share by Application in 2023 & 2030
• Figure 8. Hospital
• Figure 9. Clinic
• Figure 10. Others
• Figure 11. Contact-Activated Lancet Report Years Considered
• Figure 12. Global Contact-Activated Lancet Revenue, (US$ Million), 2019 VS 2023 VS 2030
• Figure 13. Global Contact-Activated Lancet Revenue 2019-2030 (US$ Million)
• Figure 14. Global Contact-Activated Lancet Revenue Market Share by Region in Percentage: 2023 Versus 2030
• Figure 15. Global Contact-Activated Lancet Revenue Market Share by Region (2019-2030)
• Figure 16. Global Contact-Activated Lancet Sales 2019-2030 ((K Units)
• Figure 17. Global Contact-Activated Lancet Sales Market Share by Region (2019-2030)
• Figure 18. US & Canada Contact-Activated Lancet Sales YoY (2019-2030) & (K Units)
• Figure 19. US & Canada Contact-Activated Lancet Revenue YoY (2019-2030) & (US$ Million)
• Figure 20. Europe Contact-Activated Lancet Sales YoY (2019-2030) & (K Units)
• Figure 21. Europe Contact-Activated Lancet Revenue YoY (2019-2030) & (US$ Million)
• Figure 22. China Contact-Activated Lancet Sales YoY (2019-2030) & (K Units)
• Figure 23. China Contact-Activated Lancet Revenue YoY (2019-2030) & (US$ Million)
• Figure 24. Asia (excluding China) Contact-Activated Lancet Sales YoY (2019-2030) & (K Units)
• Figure 25. Asia (excluding China) Contact-Activated Lancet Revenue YoY (2019-2030) & (US$ Million)
• Figure 26. Middle East, Africa and Latin America Contact-Activated Lancet Sales YoY (2019-2030) & (K Units)
• Figure 27. Middle East, Africa and Latin America Contact-Activated Lancet Revenue YoY (2019-2030) & (US$ Million)
• Figure 28. The Contact-Activated Lancet Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
• Figure 29. The Top 5 and 10 Largest Manufacturers of Contact-Activated Lancet in the World: Market Share by Contact-Activated Lancet Revenue in 2023
• Figure 30. Global Contact-Activated Lancet Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
• Figure 31. Global Contact-Activated Lancet Sales Market Share by Type (2019-2030)
• Figure 32. Global Contact-Activated Lancet Revenue Market Share by Type (2019-2030)
• Figure 33. Global Contact-Activated Lancet Sales Market Share by Application (2019-2030)
• Figure 34. Global Contact-Activated Lancet Revenue Market Share by Application (2019-2030)
• Figure 35. US & Canada Contact-Activated Lancet Sales Market Share by Type (2019-2030)
• Figure 36. US & Canada Contact-Activated Lancet Revenue Market Share by Type (2019-2030)
• Figure 37. US & Canada Contact-Activated Lancet Sales Market Share by Application (2019-2030)
• Figure 38. US & Canada Contact-Activated Lancet Revenue Market Share by Application (2019-2030)
• Figure 39. US & Canada Contact-Activated Lancet Revenue Share by Country (2019-2030)
• Figure 40. US & Canada Contact-Activated Lancet Sales Share by Country (2019-2030)
• Figure 41. U.S. Contact-Activated Lancet Revenue (2019-2030) & (US$ Million)
• Figure 42. Canada Contact-Activated Lancet Revenue (2019-2030) & (US$ Million)
• Figure 43. Europe Contact-Activated Lancet Sales Market Share by Type (2019-2030)
• Figure 44. Europe Contact-Activated Lancet Revenue Market Share by Type (2019-2030)
• Figure 45. Europe Contact-Activated Lancet Sales Market Share by Application (2019-2030)
• Figure 46. Europe Contact-Activated Lancet Revenue Market Share by Application (2019-2030)
• Figure 47. Europe Contact-Activated Lancet Revenue Share by Country (2019-2030)
• Figure 48. Europe Contact-Activated Lancet Sales Share by Country (2019-2030)
• Figure 49. Germany Contact-Activated Lancet Revenue (2019-2030) & (US$ Million)
• Figure 50. France Contact-Activated Lancet Revenue (2019-2030) & (US$ Million)
• Figure 51. U.K. Contact-Activated Lancet Revenue (2019-2030) & (US$ Million)
• Figure 52. Italy Contact-Activated Lancet Revenue (2019-2030) & (US$ Million)
• Figure 53. Netherlands Contact-Activated Lancet Revenue (2019-2030) & (US$ Million)
• Figure 54. China Contact-Activated Lancet Sales Market Share by Type (2019-2030)
• Figure 55. China Contact-Activated Lancet Revenue Market Share by Type (2019-2030)
• Figure 56. China Contact-Activated Lancet Sales Market Share by Application (2019-2030)
• Figure 57. China Contact-Activated Lancet Revenue Market Share by Application (2019-2030)
• Figure 58. Asia Contact-Activated Lancet Sales Market Share by Type (2019-2030)
• Figure 59. Asia Contact-Activated Lancet Revenue Market Share by Type (2019-2030)
• Figure 60. Asia Contact-Activated Lancet Sales Market Share by Application (2019-2030)
• Figure 61. Asia Contact-Activated Lancet Revenue Market Share by Application (2019-2030)
• Figure 62. Asia Contact-Activated Lancet Revenue Share by Region (2019-2030)
• Figure 63. Asia Contact-Activated Lancet Sales Share by Region (2019-2030)
• Figure 64. Japan Contact-Activated Lancet Revenue (2019-2030) & (US$ Million)
• Figure 65. South Korea Contact-Activated Lancet Revenue (2019-2030) & (US$ Million)
• Figure 66. China Taiwan Contact-Activated Lancet Revenue (2019-2030) & (US$ Million)
• Figure 67. Southeast Asia Contact-Activated Lancet Revenue (2019-2030) & (US$ Million)
• Figure 68. India Contact-Activated Lancet Revenue (2019-2030) & (US$ Million)
• Figure 69. Middle East, Africa and Latin America Contact-Activated Lancet Sales Market Share by Type (2019-2030)
• Figure 70. Middle East, Africa and Latin America Contact-Activated Lancet Revenue Market Share by Type (2019-2030)
• Figure 71. Middle East, Africa and Latin America Contact-Activated Lancet Sales Market Share by Application (2019-2030)
• Figure 72. Middle East, Africa and Latin America Contact-Activated Lancet Revenue Market Share by Application (2019-2030)
• Figure 73. Middle East, Africa and Latin America Contact-Activated Lancet Revenue Share by Country (2019-2030)
• Figure 74. Middle East, Africa and Latin America Contact-Activated Lancet Sales Share by Country (2019-2030)
• Figure 75. Brazil Contact-Activated Lancet Revenue (2019-2030) & (US$ Million)
• Figure 76. Mexico Contact-Activated Lancet Revenue (2019-2030) & (US$ Million)
• Figure 77. Turkey Contact-Activated Lancet Revenue (2019-2030) & (US$ Million)
• Figure 78. Israel Contact-Activated Lancet Revenue (2019-2030) & (US$ Million)
• Figure 79. GCC Countries Contact-Activated Lancet Revenue (2019-2030) & (US$ Million)
• Figure 80. Contact-Activated Lancet Value Chain
• Figure 81. Contact-Activated Lancet Production Process
• Figure 82. Channels of Distribution
• Figure 83. Distributors Profiles
• Figure 84. Bottom-up and Top-down Approaches for This Report
• Figure 85. Data Triangulation
• Figure 86. Key Executives Interviewed